JP Morgan Maintains Overweight on RH, Lowers Price Target to $212

Benzinga Newsdesk www.benzinga.com Negative 87.3%

Neg 87.3% Neu 0% Pos 0%

JP Morgan analyst Christopher Horvers maintains RH (NYSE:RH) with a Overweight and lowers the price target from $225 to $212.